Bahrain is actively participating in the UAE's phase III clinical trials for the COVID-19 vaccine.
According to Ashish Koshy, the CEO of G42 Healthcare, Bahrain is working on enrolling and vaccinating close to 6,000 volunteers.
He clarified that this expansion enforces the ongoing collaboration between the two countries.
Speaking to ARN News, Koshy revealed that there will be more collaborations in the future.
He explained that the current trials have also shown positive results so far.


Indian educator wins $1 million Global Teacher Prize
UAE President honours Zayed Award for Human Fraternity winners
Abu Dhabi launches self-generated solar power plan
UAE hosts second round of trilateral talks on Ukraine
UAE expert named on UN panel shaping global AI governance